Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Latest filing published 06 Oct 2026 for Eton Pharmaceuticals, Inc.. Read the official filing
Filing timeline
BuySaleDavid Krempa
Insider track record
Disclosed buys
0
Disclosed sells
8
Signal history
David Krempa: trading record in brief
This profile gathers the share dealings of David Krempa in Eton Pharmaceuticals, Inc., where the filings describe the role as senior executive. In total, 18 filings cover trades dated from 12 June 2025 to 6 October 2026.
On the market, this insider has only sold: 8 sales, €4.6M in total. Besides market trades, the filings include 2 share grants and 8 option exercises. So far in 2026, the count stands at no purchases and 7 sales.
The latest filing, published on 6 October 2026, reports an open-market sale of €204k in Eton Pharmaceuticals, Inc. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David Krempa
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
10,522 sharesCommon StockSEC:0001437749-26-032240:0
4,166 shares@ US$55.0663Common StockSEC:0001437749-26-032240:1
25,000 shares@ US$7.310.011% mcap3.2% of flowCommon StockSEC:0001437749-26-028846:0
25,000 shares@ US$65.070.100% mcap28.8% of flowCommon StockSEC:0001437749-26-028846:1
10,000 sharesCommon StockSEC:0001437749-26-023440:0
32,963 shares@ US$33.22080.061% mcap19.5% of flowCommon StockSEC:0001437749-26-018628:1
519 shares@ US$35.000.0010% mcap0.3% of flowCommon StockSEC:0001437749-26-018628:3
25,000 shares@ US$1.380.0019% mcap0.6% of flowCommon StockSEC:0001437749-26-018628:4
37,524 shares@ US$31.49270.065% mcap21.0% of flowCommon StockSEC:0001437749-26-018628:6
19,679 shares@ US$31.47390.034% mcap11.0% of flowCommon StockSEC:0001437749-26-018628:9
30,591 shares@ US$3.580.0061% mcap1.9% of flowCommon StockSEC:0001437749-26-018628:0
9,315 shares@ US$33.88020.018% mcap5.6% of flowCommon StockSEC:0001437749-26-018628:2
12,524 shares@ US$1.370.0010% mcap0.3% of flowCommon StockSEC:0001437749-26-018628:5
12,476 shares@ US$1.370.0009% mcap0.3% of flowCommon StockSEC:0001437749-26-018628:7
7,203 shares@ US$3.580.0014% mcap0.5% of flowCommon StockSEC:0001437749-26-018628:8
1,942 shares@ US$15.620.0017% mcap0.5% of flowCommon StockSEC:0001437749-26-001288:0
6,264 shares@ US$17.000.0058% mcap1.9% of flowCommon StockSEC:0001437749-25-037745:0
16,977 shares@ US$14.924.5% of flowCommon StockSEC:0001437749-25-020518:0
18 of 18 declarations
